Abstract Pre-adolescent girls (9–15 years) have the option of receiving a two dose HPV
vaccine series at either a six month or one year interval to provide protection from HPV 16 …

Cervarix® and Gardasil® are two prophylactic HPV vaccines designed primarily for cervical
cancer prevention. Cervarix is effective against HPV-16,-18,-31,-33 and-45, the five most …

Cervical cancer continues to be the second largest cause of cancer deaths in women
worldwide. Persistent infection with high-risk types of human papillomavirus (HPV) is a …

Persistent infection with human papillomavirus (HPV) is a necessary cause of cervical
cancer, resulting annually in 274,000 deaths worldwide. Two prophylactic HPV vaccines are …

This observer-blind study compared the prophylactic human papillomavirus (HPV) vaccines,
Cervarix™(GlaxoSmithKline) and Gardasil®(Merck), by assessing immunogenicity and …

Since the discovery of the causal association between human papillomavirus (HPV) and
cervical cancer, efforts to develop an effective prophylactic vaccine to prevent high-risk HPV …

Abstract▴ Human papillomavirus (HPV) quadrivalent recombinant vaccine is a mixture of
virus-like particles derived from the L1 capsid proteins of HPV types 6, 11, 16 and 18. It is …

Immunization is the most successful method in preventing and controlling infectious
diseases, which has helped saving millions of lives worldwide. The discovery of the human …

Human papillomavirus (HPV) is the most common sexually transmitted infection, with 15
HPV types related to cervical, anal, oropharyngeal, penile, vulvar, and vaginal cancers …

Approaches for cervical cancer prevention are changing. Screening still remains the most
effective method for cervical cancer prevention. Guidelines are moving to an older group of …